Literature DB >> 26518336

Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts.

J N Caviness1, R L Utianski1, J G Hentz1, T G Beach2, B N Dugger2, H A Shill2, E D Driver-Dunckley1, M N Sabbagh2, S Mehta1, C H Adler1.   

Abstract

BACKGROUND AND
PURPOSE: It is believed that progressive Lewy-type synucleinopathy (LTS) is primarily responsible for the worsening of motor and non-motor Parkinson's disease (PD) signs and symptoms. Characterization of quantitative electroencephalography (QEEG) abnormalities across the spectrum of LTS to PD dementia (PD-D) may provide insight into the pathophysiology of PD cortical dysfunction. Here our enlarged EEG database was leveraged to characterize spectral QEEG abnormalities in asymptomatic autopsy-defined groups of control participants and incidental Lewy body disease (ILBD) and three clinically defined groups of participants with PD (cognitively normal PD, mild cognitive impairment PD, and PD-D).
METHODS: The PD cohort was studied as part of the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND). AZSAND utilizes its Brain and Body Donation Program to perform prospective, standardized, regular longitudinal pre-mortem assessments until death. Resting EEG from subjects was analyzed for spectral domain QEEG measures of background rhythm frequency and global relative power in delta, theta, alpha and beta bands.
RESULTS: The various spectral QEEG measures showed differential changes specific to the groups compared. Important findings were background rhythm frequency showing the most pairwise differences across the groups, and this also was the only significant difference between control and ILBD. An increase in delta bandpower was characteristic of worsening cognitive deficits.
CONCLUSIONS: Different patterns of change amongst QEEG measures across LTS and PD cognitive states suggest that they correlate with heterogeneous pathophysiologies of cortical dysfunction within the PD clinical spectrum. In addition, the biomarker application of a specific spectral QEEG measure needs to be selectively suited to its study purpose.
© 2015 EAN.

Entities:  

Keywords:  EEG; Parkinson's disease; biomarker; dementia; pathology; synucleinopathy

Mesh:

Substances:

Year:  2015        PMID: 26518336     DOI: 10.1111/ene.12878

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  11 in total

1.  EEG Mu (µ) rhythm spectra and oscillatory activity differentiate stuttering from non-stuttering adults.

Authors:  Tim Saltuklaroglu; Ashley W Harkrider; David Thornton; David Jenson; Tiffani Kittilstved
Journal:  Neuroimage       Date:  2017-04-09       Impact factor: 6.556

2.  Mid-frontal theta activity is diminished during cognitive control in Parkinson's disease.

Authors:  Arun Singh; Sarah Pirio Richardson; Nandakumar Narayanan; James F Cavanagh
Journal:  Neuropsychologia       Date:  2018-05-23       Impact factor: 3.139

Review 3.  Electroencephalogram in dementia with Lewy bodies: a systematic review.

Authors:  Simela Chatzikonstantinou; Jack McKenna; Eleni Karantali; Fivos Petridis; Dimitrios Kazis; Ioannis Mavroudis
Journal:  Aging Clin Exp Res       Date:  2020-05-07       Impact factor: 3.636

4.  NREM Sleep EEG Characteristics Correlate to the Mild Cognitive Impairment in Patients with Parkinsonism.

Authors:  Cheng Zhang; Luhua Wei; Fengqingyang Zeng; Tingwei Zhang; Yunchuang Sun; Yane Shen; Guangfa Wang; Jing Ma; Jue Zhang
Journal:  Biomed Res Int       Date:  2021-07-24       Impact factor: 3.411

Review 5.  Quantitative EEG parameters correlate with the progression of human prion diseases.

Authors:  Edit Franko; Tim Wehner; Olivier Joly; Jessica Lowe; Marie-Claire Porter; Joanna Kenny; Andrew Thompson; Peter Rudge; John Collinge; Simon Mead
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-07-13       Impact factor: 10.154

6.  Personalized transcranial alternating current stimulation (tACS) and physical therapy to treat motor and cognitive symptoms in Parkinson's disease: A randomized cross-over trial.

Authors:  Alessandra Del Felice; Leonora Castiglia; Emanuela Formaggio; Manuela Cattelan; Bruno Scarpa; Paolo Manganotti; Elena Tenconi; Stefano Masiero
Journal:  Neuroimage Clin       Date:  2019-03-18       Impact factor: 4.881

7.  The Application of EEG Mu Rhythm Measures to Neurophysiological Research in Stuttering.

Authors:  David Jenson; Andrew L Bowers; Daniel Hudock; Tim Saltuklaroglu
Journal:  Front Hum Neurosci       Date:  2020-01-10       Impact factor: 3.473

8.  Quantitative Electroencephalography (QEEG) as an Innovative Diagnostic Tool in Mental Disorders.

Authors:  Marta Kopańska; Danuta Ochojska; Agnieszka Dejnowicz-Velitchkov; Agnieszka Banaś-Ząbczyk
Journal:  Int J Environ Res Public Health       Date:  2022-02-21       Impact factor: 3.390

9.  The Impact of Robotic Rehabilitation on the Motor System in Neurological Diseases. A Multimodal Neurophysiological Approach.

Authors:  Zoltán Zsigmond Major; Calin Vaida; Kinga Andrea Major; Paul Tucan; Gábor Simori; Alexandru Banica; Emanuela Brusturean; Alin Burz; Raul Craciunas; Ionut Ulinici; Giuseppe Carbone; Bogdan Gherman; Iosif Birlescu; Doina Pisla
Journal:  Int J Environ Res Public Health       Date:  2020-09-09       Impact factor: 3.390

10.  Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson's Disease.

Authors:  Kevin Novak; Bruce A Chase; Jaishree Narayanan; Premananda Indic; Katerina Markopoulou
Journal:  Front Aging Neurosci       Date:  2022-01-03       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.